Literature DB >> 29155299

Evaluation of inositol phosphates in urine after topical administration of myo-inositol hexaphosphate to female Wistar rats.

F Grases1, A Costa-Bauzá2, F Berga2, A Rodríguez2, R M Gomila3, G Martorell3, M R Martínez-Cignoni4.   

Abstract

AIMS: Previous studies demonstrated a remarkable increase of urinary InsP6 by topical administration. However, the methodology used for InsP6 analysis was not specific. The aim of this paper is to measure urinary inositol phosphates InsPs using more advanced methodologies and to compare the results with those obtained by the non-specific method.
MATERIALS AND METHODS: We fed 12 female rats with a diet without InsP6 for 16days. Then, we administered a topical InsP6 gel at high doses for 7days (50mgInsP6/day) or at low doses for 28days (20mgInsP6/day). We measured urine levels InsPs using a nonspecific method (based on the ability of InsPs to complex Al3+) and levels of InsP6 by a specific method (using polyacrylamide gel electrophoresis). Identification of different InsPs was performed by MS. KEY
FINDINGS: At baseline, after dietary deprivation of InsP6, rats only excreted InsP2 in their urine, and there was no detectable InsP6 or other InsPs. Rats given the high dose treatment for 7days had abundant urinary InsP6, but also had other InsPs in their urine; cessation of InsP6 administration led to decreased levels of urinary InsPs. Rats given the low dose treatment for 28days had increasing levels of urinary InsPs over time. The maximum urinary InsP6 was at 21days, after which InsPs excretion decreased. SIGNIFICANCE: We conclude that the skin can absorb InsP6 from a topical gel, and that InsP6 is excreted in the urine, along with other InsPs (InsP5, InsP4, InsP3, and InsP2).
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inositol phosphates; Phytate; Renal excretion; Topical administration

Mesh:

Substances:

Year:  2017        PMID: 29155299     DOI: 10.1016/j.lfs.2017.11.023

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Chemoprotective effects of inositol hexaphosphate against cyclophosphamide-induced testicular damage in rats.

Authors:  Maha I Alkhalaf; Wafa S Alansari; Fawzia A Alshubaily; Afnan M Alnajeebi; Areej A Eskandrani; Manal A Tashkandi; Nouf A Babteen
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

Review 2.  Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications.

Authors:  Felix Grases; Antonia Costa-Bauza
Journal:  Molecules       Date:  2019-12-04       Impact factor: 4.411

3.  Phytate Dephosphorylation Products Also Act as Potent Inhibitors of Calcium Oxalate Crystallization.

Authors:  Felix Grases; Antonia Costa-Bauzá; Paula Calvó; Francesca Julià; Jaume Dietrich; Rosa Maria Gomila; Gabriel Martorell; Pilar Sanchis
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

4.  Intake of myo-inositol hexaphosphate and urinary excretion of inositol phosphates in Wistar rats: Gavage vs. oral administration with sugar.

Authors:  F Grases; A Costa-Bauzá; F Berga; R M Gomila; G Martorell; M R Martínez-Cignoni
Journal:  PLoS One       Date:  2019-10-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.